U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757022) titled 'AI-Driven Digital Twin and Drug Simulation for Esophageal Cancer' on July 30.
Brief Summary: This study aims to integrate multi-omics data (genomics, transcriptomics, proteomics) from esophageal cancer patients with artificial intelligence and digital twin technology to construct personalized virtual patient models that precisely simulate individual responses to targeted therapies. Through a drug simulation platform, this study will rapidly screen potential effective drug combinations and optimize dosage and treatment regimens. The project attempts to replace portions of traditional clinical trials with virtual clinical trial techno...